R. Douglas Bruce, MD, MA, MS

• Dr. Bruce has worked to develop and implement research and public health interventions both locally and internationally. From drug-drug interaction work to ascertain the impact of HIV and HCV therapeutics on methadone/buprenorphine and operations research to improve HIV/HCV and tuberculosis care, he has translated research into clinical environments to improve outcomes for marginalized populations and to reduce health disparities. Dr. Bruce supported the launch of the first public methadone program in Sub-Sahara Africa in Dar es Salaam, Tanzania. Dr. Bruce has provided technical assistance to the CDC (Kenya, Tanzania, and India), the United Nations (Mauritius, Kenya, and Seychelles), USAID (Ukraine), and non-governmental organizations to address HIV and substance use epidemics globally. Dr. Bruce has held academic appointments at Yale School of Medicine, Yale School of Public Health, Boston University School of Medicine, and Case Western Reserve.